INVO Fertility, Inc.
IVF · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2 | $2 | $2 | $2 |
| % Growth | -5.7% | 13.8% | -2.9% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $1 |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 35.8% | 41.3% | 36.2% | 43.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2 | $2 | $3 | $3 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $2 | $15 | $1 |
| Operating Expenses | $2 | $4 | $18 | $5 |
| Operating Income | -$2 | -$3 | -$17 | -$4 |
| % Margin | -93.1% | -160.4% | -1,044.9% | -235.8% |
| Other Income/Exp. Net | -$1 | -$0 | -$0 | $0 |
| Pre-Tax Income | -$3 | -$3 | -$17 | -$4 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$3 | -$5 | -$17 | -$4 |
| % Margin | -150.5% | -283.6% | -1,063% | -214.9% |
| EPS | -0.77 | -39.9 | -56.22 | -9.04 |
| % Growth | 98.1% | 29% | -521.9% | – |
| EPS Diluted | -0.77 | -39.9 | -56.22 | -9.04 |
| Weighted Avg Shares Out | 3 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 3 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$3 | -$17 | -$3 |
| % Margin | -85.3% | -151.2% | -1,029.7% | -190.6% |